Product Description
The global catheter securement market was valued at $2.2 billion in 2025. This is expected to increase over the forecast period at a CAGR of 3.2% to reach $2.7 billion by 2032.
The full report suite on the global market for catheter securement includes tape and dressings, and manufactured catheter securement devices (MCSDs) and sutures.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Catheter Securement Market Trends
Unit demand for catheter securement products is fundamentally tied to catheter insertion volumes and underlying patient demographics. The widespread use of intravenous therapy across inpatient settings supports a large and recurring demand base for securement solutions. As populations age and the prevalence of chronic conditions rises, overall catheter utilization is expected to increase, sustaining growth in securement device unit sales even in the absence of rapid price expansion.
Catheter Securement Market Share Insights
- Solventum, in 2025, emerged as the leading company in catheter securement following its spin-off from 3M in April 2024. The company held the dominant share for the dressing market, especially with its Tegaderm™ line. Products such as the Tegaderm™ CHG antimicrobial dressing strengthen its market position, though sold at a premium. Solventum also offers Medipore™ dressings, widely used for IV securement and wound care, and has a presence in manufactured securement devices through its PICC/CVC Securement Device + Tegaderm series, which holds a modest but notable share of the MCSD market.
- Becton Dickinson (BD) stood out as the major competitor in the manufactured catheter securement market, particularly with its StatLock® line of products acquired in 2006. BD’s stronghold in PICC, chronic central venous catheter (CVC) and midline catheter markets enabled it to dominate the manufactured catheter securement landscape, both independently and within catheter kits. However, competition and hesitance from competitors to directly purchase from BD resulted in some erosion of BD’s market share, though StatLock® remained the dominant player.
- Smith & Nephew held a significant share in the dressings market, catering to catheter securement and other needs. Its IV3000® dressings were used for IV site care, available in various sizes for securement of peripheral and central lines. The IV3000® 1-Hand Delivery offered easy application, and the company also provided HYPAFIX® tape for PIVC securement.
Catheter Securement Market Segmentation Summary
- Catheter Securement Market – Further Segmented Into:
- Device Type: Tape and Dressing (Antimicrobial & Standard), Suture, and Manufactured Catheter Securement Device (Mechanical & Non-Mechanical)
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
